QF

Qun Kevin Fang

SE Sepracor: 24 patents #8 of 121Top 7%
SP Sunovion Pharmaceuticals: 12 patents #12 of 118Top 15%
📍 Wellesley, MA: #32 of 837 inventorsTop 4%
🗺 Massachusetts: #2,153 of 88,656 inventorsTop 3%
Overall (All Time): #90,191 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 1–25 of 37 patents

Patent #TitleCo-InventorsDate
10702486 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Thomas Jerussi, Mark G. Currie 2020-07-07
10328036 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Thomas Jerussi, Mark G. Currie 2019-06-25
9907764 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Thomas Jerussi, Mark G. Currie 2018-03-06
9884844 Heterocyclic compounds and methods of use thereof Una Campbell, Kerry L. Spear 2018-02-06
9498452 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Thomas Jerussi, Mark G. Currie 2016-11-22
9072699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2015-07-07
8658700 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2014-02-25
8497278 Imidazo[1,2-a]pyridine compounds Frank Xinhe Wu, Paul Grover, Seth Cabot Hopkins, Una Campbell, Milan Chytil +1 more 2013-07-30
8404670 Histamine H3 inverse agonists and antagonists and methods of use thereof Milan Chytil, Sharon Engel, Kerry L. Spear 2013-03-26
8344030 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2013-01-01
8134029 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2012-03-13
8063032 Histamine H3 inverse agonists and antagonists and methods of use thereof Milan Chytil, Kerry L. Spear 2011-11-22
7902252 Inhibitors of D-amino acid oxidase Michele L. R. Heffernan, Robert J. Foglesong, Seth Cabot Hopkins, Cyprian O. Ogbu, Mustapha Soukri +1 more 2011-03-08
7790772 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2010-09-07
7589237 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2009-09-15
7579370 Fused heterocycles Michele L. R. Heffernan, James M. Dorsey, Robert J. Foglesong, Seth Cabot Hopkins, Cyprian O. Ogbu +2 more 2009-08-25
7456173 Compositions comprising zopiclone derivatives and methods of making and using the same Thomas Jerussi 2008-11-25
7423179 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Thomas Jerussi, Mark G. Currie 2008-09-09
7189715 Compositions comprising zopiclone derivatives and methods of making and using the same Thomas Jerussi 2007-03-13
7105699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Thomas Jerussi, Mark G. Currie 2006-09-12
7087785 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Thomas Jerussi, Mark G. Currie 2006-08-08
7071234 Methods of treating or preventing erectile dysfunction Thomas Jerussi, Chrisantha H. Senanayake 2006-07-04
6974838 Methods of treating or preventing pain using sibutramine metabolites Chrisantha H. Senanayake, Zhengxu Han, Dhileepkumar Krishnamurthy 2005-12-13
6974837 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors Thomas Jerussi, Chrisantha H. Senanayake 2005-12-13
6780891 Tramadol analogs and uses thereof Chris Hugh Senanayake, Thomas Jerussi, Paul Grover, Mark G. Currie 2004-08-24